In a groundbreaking move, a high-ranking official from the Department of Health and Human Services (HHS) has made a momentous recommendation that could reshape the landscape of cannabis prohibition in the United States. HHS has formally proposed the reclassification of cannabis from Schedule I to Schedule III under the Controlled Substances Act, a significant shift that reflects a changing perspective on the plant’s classification. For reference, see the DEA’s CSA chart here.
This historic announcement marks the first time a major government agency has acknowledged the erroneous categorization of cannabis as a highly dangerous substance with no recognized medical benefits. The decision to move cannabis to Schedule III comes after an exhaustive year-long investigation.
MoCann’s national industry association partner ATACH (American Trade Association For Cannabis and Hemp) has assembled a Q & A overview on the impact rescheduling cannabis from Schedule I to Schedule III would have on our industry. The document also does a great job of answering the many other relevant questions our industry would have concern for if the DEA adopts HHS’s recommendation.
ATACH: The American Trade Association for Cannabis and Hemp (ATACH) is the leading United States 501(c)(6) cannabis industry trade organization promoting the expansion and protection of legal sales of cannabis and hemp for industrial, medical, and adult use.